Having experienced the effects of reduced on-site access, the urgency for pharmaceutical and biotech companies to implement digital tools and platforms to support R&D has never been higher.
TORONTO (PRWEB) April 15, 2021
The global pandemic has put pressure on all areas of the drug discovery and development pipeline. Having experienced the effects of reduced on-site access, the urgency for pharmaceutical and biotech companies to implement digital tools and platforms to support R&D has never been higher.
This 45-minute panel discussion will focus on bioprocess development, and our panel of automation and bioprocessing experts from UCB Pharma, Digital Lab Consulting and Synthace will share with you their lessons and recommendations from various stages of their digitization journeys.
Register for the webinar today to learn all about the following:
- Where and how to begin? Does digitization have to come from the top, or can you drive organizational change from the ground up?
- What areas in bioprocess development are more suitable for quick wins and what has already been achieved?
- How can the integration of laboratory automation and data be made easier to achieve?
- How do you balance driving changes to how scientists work against pressure to deliver in a fast-paced organization?
- How do you set time and resource expectations with your stakeholders?
Don’t miss this opportunity to interact directly with expert speakers to help you build on your own digitization strategies. Join Dr. Alexandre Super, Data Scientist - Upstream Process Sciences, UCB Pharma; Dr. Eliot Randle, MBA, Managing Partner & Co-Founder, Digital Lab Consulting; Dr. Sarah James, Senior Field Application Scientist, Synthace; and Adam Paton, Biologics Director, Synthace for the live webinar on Tuesday, May 4, 2021 at 11am EDT (4pm BST/UK).
Adam Paton, Biologics Director, Synthace commented: “As technology for the life sciences has become increasingly sophisticated, the bioprocessing community have adapted to new ways of enhancing the speed and reliability of their research and development. I am thrilled to join other experts in this field to discuss how we can continue to evolve our processes and help reduce the time needed for life-changing products to reach those in need, especially after such a tumultuous year around the world.”
For more information, or to register for this event, visit Building Digitally Empowered Bioprocess Development Organizations to Accelerate Product Release.
Based in Boston, US and London,UK, Synthace is accelerating biological discovery & optimisation through computer-aided biology. Our cloud software platform, Antha, empowers biologists by enabling them to flexibly program their lab automation without the need to code. The graphical user interface has been designed by biologists for biologists, intuitively enabling them to automate their whole experiment from planning to execution, data collection and analysis. Antha is the cornerstone of the lab of the future, seamlessly connecting the digital realm of data with the physical of lab automation and wet-lab biology, automatically collecting and structuring data to accelerate biological understanding.
Synthace is unlocking the potential of biology for humankind and our environment. Synthace works with biopharmaceutical companies, and in 2016 was recognized by the World Economic Forum as a Technology Pioneer that is helping shape the Fourth Industrial Revolution, and in 2018 as a cool vendor by Gartner.
To learn more about Synthace visit https://www.synthace.com/